Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Allergy|October 26, 2017
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsI Kortekaas Krohn, M M Shikhagaie, K Golebski, et al.
Frontiers in Allergy|May 30, 2024
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthmaG K Scadding, C Gray, D M Conti, et al.
Allergy|December 18, 2023
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for ImmunopharmacologyF Roth-Walter, I M Adcock, C Benito-Villalvilla, et al.
Allergy|February 7, 2026
Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small MoleculesF Roth-Walter, I M Adcock, C Benito-Villalvilla, et al.
Frontiers in Allergy|February 14, 2024
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthmaG K Scadding, M McDonald, V Backer, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Frontiers in Allergy|August 14, 2023
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory careP W Hellings, S Lau, G K Scadding, et al.
Rhinology|March 5, 2025
Pocket guide: biologics in upper and lower airways in adultsW J Fokkens, V Backer, V J Lund, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Rhinology|February 17, 2026
Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSORT Bartosik, S F Seys, J de Kinderen, et al.
Pageof 12